Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

AMN Healthcare Services, Inc. (AMN) SEC Filings & Earnings Calls

EquiReason read 9 AMN Healthcare Services, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Revenue $673M (+2% y/y); Revenue $2.05B (+52% y/y); Gross margin 30.6.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AMNAMN Healthcare Services, Inc.Follow AMN — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
1.9B
P/E TTM
17.8
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

7 Aug 202610-QRevenue $673M (+2% y/y); Revenue $2.05B (+52% y/y); Gross margin 30.6open

Figures in the filing · each found in the filing text

Revenue · consolidated · Q2-2026$673M+2% y/y
Revenue · consolidated · H1-2026$2.05B+52% y/y
Gross margin · consolidated · Q2-202630.6%
Net cash provided by operating activities · consolidated · H1-2026$373M+118% y/y
Average travelers on assignment · nurse_and_allied_solutions · Q2-20266.0%
Days filled (locum tenens) · physician_and_leadership_solutions · Q2-2026-8.0%

Risks flagged

Labor disruption revenue volatility

“Even if somewhat recurrent over the long term, labor disruption events are unpredictable and have driven spikes in demand and related financial outcomes when they happen.” · word for word

Pricing pressure in language services

“Ongoing pricing pressure for language services continues to be a headwind due to increased market competition.” · word for word

Client losses in VMS business

“our VMS business declined $3.9 million (or 20%) due to lower staffing utilization on the platforms along with several client losses.” · word for word
Read the original on SEC EDGAR ↗
8 May 202610-QRevenue $1.38B (+100% y/y); Nurse and allied solutions revenue $1.13B (+173% y/y); Physician and leadership solutions revenue $164M (-6% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$1.38B+100% y/y
Nurse and allied solutions revenue · Nurse and allied solutions · Q1-2026$1.13B+173% y/y
Physician and leadership solutions revenue · Physician and leadership solutions · Q1-2026$164M-6% y/y
Technology and workforce solutions revenue · Technology and workforce solutions · Q1-2026$87M-15% y/y
Gross profit · Q1-2026$369M+86% y/y
Gross margin · Q1-202626.8%
Operating cash flow · Q1-2026$562M+507% y/y
Average travelers on assignment · Nurse and allied solutions · Q1-20263.0%
Average bill rate · Nurse and allied solutions · Q1-20266.0%

Risks flagged

Language Services Pricing Pressure

“Ongoing pricing pressure for language services is expected due to increased market competition.” · word for word

Physician and Leadership Solutions Demand Weakness

“Demand for our locum tenens staffing business in the first quarter increased slightly from prior year but decreased sequentially.” · word for word

VMS Business Decline

“Revenue for our VMS business declined $3.5 million (or 18%) due to lower staffing utilization on the platforms along with several client losses.” · word for word
Read the original on SEC EDGAR ↗
4 May 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersSEC ↗
18 Mar 2026DEF 14AAdjusted EBITDA $234M (-29% y/y); Free Cash Flow $269M; Net Debt Reduction $285M; Guidance: 2026 bonus structure modified: 45% Pre-Bonus AEBITDA, 25% revenue, 30% leadershipopen

Figures in the filing · each found in the filing text

Adjusted EBITDA · FY2025$234M-29% y/y
Free Cash Flow · FY2025$269M
Net Debt Reduction · FY2025$285M
Pre-Bonus Adjusted EBITDA · FY2025$243M
Nurse & Allied Solutions Revenue · Nurse & Allied Solutions · FY2025$1.65B
Physician & Leadership Solutions Revenue · Physician & Leadership Solutions · FY2025$696M
Technology & Workforce Solutions Revenue · Technology & Workforce Solutions · FY2025$387M
Passport Registered Users · 2025-12-31340,000
Client Satisfaction Score · FY202592.0%

Guidance

2026 bonus structure modified: 45% Pre-Bonus AEBITDA, 25% revenue, 30% leadership

Management expects improved business trends in 2026 but acknowledges ongoing challenges. No specific revenue or EPS guidance provided.

Risks flagged

Policy Uncertainty Risk

“Clients remain focused on cost containment, reimbursement rates are pressured, and policy uncertainty persists.” · word for word

Revenue Decline Risk

“Revenue declined by 8%” · word for word

Margin Compression Risk

“Consolidated Adjusted EBITDA declined by 29%” · word for word

Credit Rating Downgrade Risk

“Moody’s and Fitch Ratings have both downgraded AMN’s credit ratings in 2025.” · word for word
Read the original on SEC EDGAR ↗
20 Feb 202610-KMSP spend under management $1.80B; VMS spend flow $1.40B; Passport registered users 340,000open

Figures in the filing · each found in the filing text

MSP spend under management · Technology and Workforce Solutions · FY2025$1.80B
VMS spend flow · Technology and Workforce Solutions · FY2025$1.40B
Passport registered users · January 2026340,000

Risks flagged

Client concentration risk (Kaiser 22% of revenue)

“Kaiser Foundation Hospitals (and its affiliates) comprised approximately 22% of our consolidated revenue in 2025.”

Economic downturn impact on demand

“Demand for staffing services is sensitive to changes in economic activity. Many healthcare facilities utilize temporary healthcare professionals to accommodate an increase in hospital admissions. Conversely, when hospital admissions decrease in economic downturns or periods of high inflation, due to reduced consumer spending, the demand for our temporary hea” · word for word

Independent contractor classification risk

“Historically, we have treated our locum tenens, which include physicians and certain advanced practitioners, such as certified nurse anesthetists, nurse practitioners and physician assistants, as independent contractors.” · word for word
Read the original on SEC EDGAR ↗
5 Feb 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

Board transition risk: Low; routine retirement and nomination.

“Departure not due to disagreement; successor identified.”
Read the original on SEC EDGAR ↗
14 Jan 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
7 Nov 202510-QRevenue $634M (-8% y/y); Gross Margin 29.1; Operating Cash Flow $194M (-22% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q3-2025$634M-8% y/y
Gross Margin · Q3-202529.1%
Operating Cash Flow · 9M-2025$194M-22% y/y
Nurse and Allied Solutions Revenue · nurse_and_allied_solutions · Q3-2025$361M-9% y/y
Physician and Leadership Solutions Revenue · physician_and_leadership_solutions · Q3-2025$178M-1% y/y
Technology and Workforce Solutions Revenue · technology_and_workforce_solutions · Q3-2025$95M-12% y/y

Risks flagged

Healthcare Staffing Demand Decline

“Revenue decreased 8% to $634.5 million for the three months ended September 30, 2025 from $687.5 million for the same period in 2024.” · word for word

Gross Margin Compression

“Gross profit decreased 13% to $184.4 million for the three months ended September 30, 2025 from $213.1 million for the same period in 2024, representing gross margins of 29.1% and 31.0%, respectively.” · word for word

Goodwill Impairment

“A goodwill impairment loss of $109.5 million was recognized in the physician and leadership solutions segment during the nine months ended September 30, 2025.” · word for word

Intangible Asset Impairment

“An impairment loss of $18.3 million was recognized for intangible assets during the nine months ended September 30, 2025.” · word for word

Language Services Pricing Pressure

“Ongoing pricing pressure for language services is expected due to increased market competition.” · word for word
Read the original on SEC EDGAR ↗
6 Nov 20258-K · 2.02Revenue $634M (-8% y/y); Gross profit $184M (-13% y/y); Net income $29M (+319% y/y); Guidance: Q4 revenue $715M-$730M; adjusted EBITDA margin 6.8%-7.3%earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$635M-8% y/y
Gross profit · Q3-2025$184M-13% y/y
Net income · Q3-2025$29M+319% y/y
Adjusted diluted EPS · Q3-2025$0.39-36% y/y
Adjusted EBITDA · Q3-2025$58M-22% y/y
Cash flow from operations · Q3-2025$23M

Guidance

Q4 revenue $715M-$730M; adjusted EBITDA margin 6.8%-7.3%

Q4 revenue expected to grow sequentially but margins remain under pressure.

Risks flagged

Revenue decline across all segments; gross margin compression; reliance on labor disruption events for growth.

“Revenue -8% YoY; gross margin -190bps; labor disruption revenue $12M in Q3, assumed ~$100M in Q4.”
Read the original on SEC EDGAR ↗

AMN Healthcare Services, Inc. — questions

What did AMN Healthcare Services, Inc. file recently?
9 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Revenue $673M (+2% y/y); Revenue $2.05B (+52% y/y); Gross margin 30.6

Every figure on this page comes from AMN Healthcare Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.